Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Observe Safety and Efficacy of Nexavar in Treatment of Kidney Cancer (POWER-NEXT)

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT01353794
First received: May 13, 2011
Last updated: January 29, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)